Supplements [in Acrobat (PDF) format, require free Acrobat Reader]

March/April

• IV Iron Use in Patients With Higher Serum Ferritin: Case Study on Anemia in Kidney Disease
• Revisions in the Prescribing Information for Epoetin alfa: Implications for Nephrology Nurses and Patients on Dialysis
• Improved Patient Outcomes in Chronic Kidney Disease: Optimizing Vitamin D Therapy

January/February

• Mineral and Bone Disorders in Patients on Dialysis: Physiology and Clinical Consequences

September/October

• Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions

• Route of Administration for Erythropoiesis-Stimulating Agents: Patient and Nursing Considerations

July-August

• Frequent Assessment of Longitudinal Laboratory Trends: A Key to Minimizing Hemoglobin Variability in Patients on Dialysis

• Important Considerations in Iron Management and Nutritional Status in Select
  Hemodialysis Populations

May-June

• Safety of Erythropoiesis Stimulating Agents in Patients on Dialysis:
  Current Issues for Nephrology Nurses

March-April

• Chronic Kidney Disease and Cardiovascular Disease:
  A Case Presentation
• Hemoglobin Variability: Managing the Higher End of the Target Range
• Improving IV Iron and Anemia Management in the Hemodialysis Setting:
  A Collaborative CQI Approach
  

January-February

• Chronic Kidney Disease and Cardiovascular Disease:
  Pathophysiologic Links
• Comorbid Diseases in Patients on Dialysis: The Impact on Anemia

November-December

• Erythropoietin Claims Monitoring Policy: Implications of the
  October 2006 Update
• Chronic Kidney Disease and Cardiovascular Disease:
  Using the ANNA Standards and Practice Guidelines to Improve Care

September-October

• The Challenges of Using Serum Ferritin to Guide IV Iron Treatment Practices in Patients on Hemodialysis With Anemia
• C-Reactive Protein and Anemia: Implications for Patients on Dialysis

July-August

• Adjusting IV Iron and EPO Doses in Patients on Hemodialysis Prior to Surgery: Can We Protect Our Patients From Iron-Deficiency Anemia?
• The KDOQI™ Clinical Practice Guidelines
  And Clinical Practice Recommendations for Treating Anemia in Patients With Chronic Kidney Disease: Implications for Nurses

May-June

• Infection and Inflammation in Patients on Dialysis: An Underlying
  Contributor to Anemia and Epoetin alfa Hyporesponse

March-April

• Erythropoietin Claims Monitoring Policy: Implications for Clinical Practice

January-February

• Morbidity and Mortality in Patients on Dialysis: The Impact of Hemoglobin Levels
  
• The Effectiveness of Low-Dose Maintenance IV Iron Therapy:
  A Dialysis Facility’s Experience

2005

---

November-December

• Nurses’ Impact on the Choice and Longevity of Vascular Access
  
• Effective and Safe IV Iron and Anemia Management During Home Hemodialysis: A Dialysis Facility’s Experience

September-October

• Hemoglobin Variability: Managing Inevitable Changes in Clinical Status
  
• Using CQI Strategies to Improve and Simplify IV Iron and Anemia Management: A Dialysis Facility's Experience
  

July-August

• Anemia Management Protocols: Providing Consistent Hemoglobin Outcomes
  

May-June

• Quality of Life in Patients on Dialysis: Benefits of Maintaining a Hemoglobin of 11 to 12 g/dL

March-April

• Patient Education and the Nursing Process: Meeting the Patient’s Needs
• The Benefits of IV Iron Therapy in Treating Anemia in Patients With Renal Disease and Comorbid Cardiovascular Disease

January-February

• Evaluating Traditional Iron Measures and Exploring New Options for Patients on Hemodialysis
• Functional Ability of Patients on Dialysis: The Critical Role of Anemia

November-December

• Managing Catheter Dysfunction for Better Patient Outcomes: A Team Approach
• Implementing an IV Iron Maintenance Regimen Protocol in a Hemodialysis Practice
• Attaining Target Hemoglobin Levels in Patients New to Dialysis: Individualizing Therapy Based on Initial Hemoglobin Levels

September-October

• Managing the Anemia of End-Stage Renal Disease After Hospitalization

July-August

• Adherence to the Dialysis Prescription:
  Partnering with Patients for Improved Outcomes

May-June

• Hemodialysis Vascular Access:
  How Do Practice Patterns Affect Outcomes?

March-April

• Increased Risk of Anemia in Dialysis Patients With Comorbid Diseases

January-February

• Red Blood Cell Physiology, Epoetin alfa, and Iron